Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.24.3
Stockholders’ Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 9 Months Ended
Apr. 05, 2024
Feb. 29, 2024
Sep. 30, 2024
Aug. 30, 2024
Aug. 29, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock, shares authorized     250,000,000     250,000,000
Common stock per share     $ 0.0001     $ 0.0001
Common stock, shares issued     5,086,985     4,345,291
Common stock, shares outsatnding     5,086,985     4,345,291
Net of proceeds shares $ 10,000          
Net proceeds from sale of common stock $ 9,190          
Reverse Stock Split [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock, shares authorized       250,000,000 500,000,000  
Common stock per share       $ 0.0001    
Common stock, shares issued       5,086,985 250,816,164  
Common stock, shares outsatnding       5,086,985 250,816,164  
Common Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Issuance of common stock and warrants in public offering, net of stock issuance cost [1]     671,033      
Common Stock [Member] | BTIG, LLC [Member] | At-The-Market Sales Agreement [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Net proceeds from sale of common stock   $ 54        
Number of shares sold   4,366,000        
Warrant [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock per share $ 15.00          
Issuance of common stock and warrants in public offering, net of stock issuance cost 666,667          
Outstanding warrants to purchase of shares     666,667      
Exercise price per share     $ 17.50      
Warrants exercisable term 5 years          
[1] Adjusted to reflect the impact of the 1-for-50 reverse stock split effective as of August 30, 2024.